Hypoglycemia unawareness

Diabetes Research and Clinical Practice

Volumn 93, Issue SUPPL. 1, 2011, Pages

  Bakatselos, Spyridon O ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Catecholamines; Diabetes mellitus; Glucagon; Hypoglycemia

Indexed keywords

GLUCOSE; HYDROCORTISONE; INSULIN;

ADRENALIN RELEASE; ARTICLE; AUTONOMIC DYSFUNCTION; AWARENESS; DIABETIC PATIENT; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; IATROGENIC DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REGULATORY MECHANISM; RISK FACTOR; RISK REDUCTION;

DIABETES MELLITUS; GLUCOSE; HUMANS; HYPOGLYCEMIA; RISK FACTORS;

EID: 84860391785     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70020-1     Document Type: Article

References (34)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-996.
2. UK Prospective Diabetes Study (UKPDS) Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1999, 354:602.
3. Bacatselos SO, Karamitsos DT, Kourtoglou GI, et al. Hypoglycemia unawareness in Type I diabetic patients under conventional insulin treatment. Diab Nutr Metab 1995, 8:267-275.
4. Ciyer PE, Davis SN, Shamoon H Hypoglycemia in Diabetes. Diabetes Care 2003, 26:1906-1912.
5. Schwartz NS, Clutter WE, Shah SD, Cryer PE Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 1987, 79:777-781.
6. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991, 260:E67-E74.
7. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenzo A, Annibale B, Lepore M, Lalli C, Sindaco P, Brunetti P, Bolli Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 1994, 37:797-807.
8. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 1988, 318:1487-1492.
9. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988, 37:901-907.
10. Segel SA, Paramore DS, Cryer PE Hypoglycemia-associated autonomie failure in advanced type 2 diabetes. Diabetes 2002, 51:724-733.
11. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH Lack of glucagon response to hypoglycemia in diabetes. Evidence for an intrinsic pancreatic alpha cell defect. Science 1973, 182:171-173.
12. Bolli G, De Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983, 32:134-141.
13. Banarer S, McGregor VP, Cryer PE Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomie response. Diabetes 2002, 51:958-965.
14. Raju B, Cryer PE Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to Hypoglycemia in Insulin-Deficient Diabetes. Diabetes 2005, 54:757-764.
15. Dagogo-Jack SE, Craft S, Cryer PE Hypoglycemia-associated autonomie failure in insulin-dependent diabetes mellitus. J Clin Invest 1993, 91:819-828.
16. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983, 308:485-491.
17. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Benedetti MM, Santeusanio F, Gerich JE, Brunetti P A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes mellitus. Diabetes 1984, 33:732-737.
18. Gold AE, MacLeod KM, Frier BM Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994, 17:697-703.
19. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 1993, 10:231-237.
20. The United Kingdom Prospective Diabetes Study Group U.K. prospective diabetes study. 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995, 44:1249-1258.
21. Cryer PE Hypoglycemia: the limiting factor in the glycaemic management of Type I and II Diabetes. Diabetologia 2002, 45:937-948.
22. Cryer PE Hypoglycemia-associated autonomie failure in diabetes. Am J Physiol 2001, 281:E1115-E1121.
23. Cryer PE Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomie failure in IDDM: a vicious cycle. Diabetes 1992, 41:255-260.
24. Heller SR, Cryer PE Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 1991, 40:223-226.
25. Davis M, Shamoon H Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 1991, 73:995-1001.
26. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santuesanio F, Brunetti P, Bolli GB Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia following institution of rational intensive insulin therapy in IDDM. Diabetologia 1994, 37:1265-1276.
27. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994, 344:283-287.
28. Dagogo-Jack S, Rattarasarn C, Cryer PE Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994, 43:1426-1434.
29. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R Role of Cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 1996, 98:680-691.
30. Raju B, McGregor VP, Cryer PE Cortisol elevations comparable to those that occur during hypoglycemia do not cause Hypoglycemia-Associated Autonomie Failure. Diabetes 2003, 52:2083-2089.
31. Boyle PJ, Kempers SF, O'Connor AM, et al. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin dependent diabetes mellitus. N. Engl. J. Med 1995, 333:1726-1731.
32. Segel SA, Fanelli CG, Dance CS, et al. Blood-to-brain glucose transport, cerebral glucose metabolism and cerebral blood flow are not increased following hypoglycemia. Diabetes 2001, 50:1911-1917.
33. Bingham EM, Dunn JT, Smith D, et al. Differential changes in brain glucose metabolism during hypoglycemia accompany loss of hypoglycemia awareness in men with type I diabetes mellitus. An [11C]-3-O-methyl-D-glucose. PET study. Diabetologia 2005, 48:2080-2089.
34. Bolli GB How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes. Diabetes Care 1999, 22(Suppl 2):B43-B52.